[go: up one dir, main page]

GB201719873D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
GB201719873D0
GB201719873D0 GBGB1719873.0A GB201719873A GB201719873D0 GB 201719873 D0 GB201719873 D0 GB 201719873D0 GB 201719873 A GB201719873 A GB 201719873A GB 201719873 D0 GB201719873 D0 GB 201719873D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1719873.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F2G Ltd
Original Assignee
F2G Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F2G Ltd filed Critical F2G Ltd
Priority to GBGB1719873.0A priority Critical patent/GB201719873D0/en
Publication of GB201719873D0 publication Critical patent/GB201719873D0/en
Ceased legal-status Critical Current

Links

GBGB1719873.0A 2017-11-29 2017-11-29 Pharmaceutical formulation Ceased GB201719873D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1719873.0A GB201719873D0 (en) 2017-11-29 2017-11-29 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1719873.0A GB201719873D0 (en) 2017-11-29 2017-11-29 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
GB201719873D0 true GB201719873D0 (en) 2018-01-10

Family

ID=60950832

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1719873.0A Ceased GB201719873D0 (en) 2017-11-29 2017-11-29 Pharmaceutical formulation

Country Status (1)

Country Link
GB (1) GB201719873D0 (en)

Similar Documents

Publication Publication Date Title
GB201807942D0 (en) Pharmaceutical formulation
IL269061A (en) Pharmaceutical composition comprising selexipag
IL271226A (en) Pharmaceutical formulation
ZA201903101B (en) Pharmaceutical formulations
HUE070046T2 (en) Pharmaceutical composition
PT3426294T (en) Pharmaceutical formulation
IL271759B1 (en) Pharmaceutical compositions comprising entrectinib
IL266537A (en) Pharmaceutical formulation
ZA202102871B (en) Pharmaceutical formulation
IL253570A0 (en) Pharmaceutical formulation
IL278927A (en) Pharmaceutical formulation
GB201712159D0 (en) Pharmaceutical composition
IL253177B (en) Pharmaceutical formulation
HUE068810T2 (en) Pharmaceutical composition
IL269239A (en) Pharmaceutical combination comprising ponesimod
GB201719447D0 (en) Pharmaceutical composition
ZA201807851B (en) Pharmaceutical formulation
SI3601277T1 (en) Pharmaceutical formulation
GB201506755D0 (en) Novel pharmaceutical formulation
IL275144A (en) Pharmaceutical formulation
IL271908A (en) Hypercompressed pharmaceutical formulations
GB201511246D0 (en) Pharmaceutical formulation
GB201719873D0 (en) Pharmaceutical formulation
GB201604545D0 (en) Novel pharmaceutical formulation
GB201708329D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)